- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.04 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 12 x PQJ: fos-choline-14(Non-covalent)
- 40 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 4 residues within 4Å:- Chain A: D.70, T.71, I.72, S.73
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: Y.144, Q.146, K.170, P.178
- Chain H: K.133
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: H.3, I.4, T.5
- Chain B: K.49
Ligand excluded by PLIPSO4.7: 3 residues within 4Å:- Chain A: W.176, H.185, R.197
Ligand excluded by PLIPSO4.8: 1 residues within 4Å:- Chain A: Q.258
Ligand excluded by PLIPSO4.9: 2 residues within 4Å:- Chain A: E.209, Y.210
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: W.25, R.232, R.263
Ligand excluded by PLIPSO4.14: 1 residues within 4Å:- Chain B: K.279
Ligand excluded by PLIPSO4.15: 5 residues within 4Å:- Chain B: S.21, S.22, D.23, K.24, H.283
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain B: K.24, W.25, R.263
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain C: D.70, T.71, I.72, S.73
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain C: Y.144, Q.146, K.170, P.178
- Chain F: K.133
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain C: H.3, I.4, T.5
- Chain D: K.49
Ligand excluded by PLIPSO4.27: 3 residues within 4Å:- Chain C: W.176, H.185, R.197
Ligand excluded by PLIPSO4.28: 1 residues within 4Å:- Chain C: Q.258
Ligand excluded by PLIPSO4.29: 2 residues within 4Å:- Chain C: E.209, Y.210
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain D: W.25, R.232, R.263
Ligand excluded by PLIPSO4.34: 1 residues within 4Å:- Chain D: K.279
Ligand excluded by PLIPSO4.35: 5 residues within 4Å:- Chain D: S.21, S.22, D.23, K.24, H.283
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain D: K.24, W.25, R.263
Ligand excluded by PLIPSO4.44: 4 residues within 4Å:- Chain E: D.70, T.71, I.72, S.73
Ligand excluded by PLIPSO4.45: 5 residues within 4Å:- Chain B: K.133
- Chain E: Y.144, Q.146, K.170, P.178
Ligand excluded by PLIPSO4.46: 4 residues within 4Å:- Chain E: H.3, I.4, T.5
- Chain F: K.49
Ligand excluded by PLIPSO4.47: 3 residues within 4Å:- Chain E: W.176, H.185, R.197
Ligand excluded by PLIPSO4.48: 1 residues within 4Å:- Chain E: Q.258
Ligand excluded by PLIPSO4.49: 2 residues within 4Å:- Chain E: E.209, Y.210
Ligand excluded by PLIPSO4.53: 3 residues within 4Å:- Chain F: W.25, R.232, R.263
Ligand excluded by PLIPSO4.54: 1 residues within 4Å:- Chain F: K.279
Ligand excluded by PLIPSO4.55: 5 residues within 4Å:- Chain F: S.21, S.22, D.23, K.24, H.283
Ligand excluded by PLIPSO4.56: 3 residues within 4Å:- Chain F: K.24, W.25, R.263
Ligand excluded by PLIPSO4.64: 4 residues within 4Å:- Chain G: D.70, T.71, I.72, S.73
Ligand excluded by PLIPSO4.65: 5 residues within 4Å:- Chain D: K.133
- Chain G: Y.144, Q.146, K.170, P.178
Ligand excluded by PLIPSO4.66: 4 residues within 4Å:- Chain G: H.3, I.4, T.5
- Chain H: K.49
Ligand excluded by PLIPSO4.67: 3 residues within 4Å:- Chain G: W.176, H.185, R.197
Ligand excluded by PLIPSO4.68: 1 residues within 4Å:- Chain G: Q.258
Ligand excluded by PLIPSO4.69: 2 residues within 4Å:- Chain G: E.209, Y.210
Ligand excluded by PLIPSO4.73: 3 residues within 4Å:- Chain H: W.25, R.232, R.263
Ligand excluded by PLIPSO4.74: 1 residues within 4Å:- Chain H: K.279
Ligand excluded by PLIPSO4.75: 5 residues within 4Å:- Chain H: S.21, S.22, D.23, K.24, H.283
Ligand excluded by PLIPSO4.76: 3 residues within 4Å:- Chain H: K.24, W.25, R.263
Ligand excluded by PLIP- 28 x ACT: ACETATE ION(Non-functional Binders)
ACT.10: 3 residues within 4Å:- Chain A: N.265, Y.266, K.267
Ligand excluded by PLIPACT.11: 5 residues within 4Å:- Chain A: K.81, R.181, E.248, K.267, D.268
Ligand excluded by PLIPACT.12: 2 residues within 4Å:- Chain A: A.1
- Chain B: Q.140
Ligand excluded by PLIPACT.17: 3 residues within 4Å:- Chain B: T.66, D.67, H.68
Ligand excluded by PLIPACT.18: 2 residues within 4Å:- Chain B: K.279, K.281
Ligand excluded by PLIPACT.19: 4 residues within 4Å:- Chain B: F.76, H.173, H.257
- Chain E: Y.210
Ligand excluded by PLIPACT.20: 1 residues within 4Å:- Chain B: R.148
Ligand excluded by PLIPACT.30: 3 residues within 4Å:- Chain C: N.265, Y.266, K.267
Ligand excluded by PLIPACT.31: 5 residues within 4Å:- Chain C: K.81, R.181, E.248, K.267, D.268
Ligand excluded by PLIPACT.32: 2 residues within 4Å:- Chain C: A.1
- Chain D: Q.140
Ligand excluded by PLIPACT.37: 3 residues within 4Å:- Chain D: T.66, D.67, H.68
Ligand excluded by PLIPACT.38: 2 residues within 4Å:- Chain D: K.279, K.281
Ligand excluded by PLIPACT.39: 4 residues within 4Å:- Chain D: F.76, H.173, H.257
- Chain G: Y.210
Ligand excluded by PLIPACT.40: 1 residues within 4Å:- Chain D: R.148
Ligand excluded by PLIPACT.50: 3 residues within 4Å:- Chain E: N.265, Y.266, K.267
Ligand excluded by PLIPACT.51: 5 residues within 4Å:- Chain E: K.81, R.181, E.248, K.267, D.268
Ligand excluded by PLIPACT.52: 2 residues within 4Å:- Chain E: A.1
- Chain F: Q.140
Ligand excluded by PLIPACT.57: 3 residues within 4Å:- Chain F: T.66, D.67, H.68
Ligand excluded by PLIPACT.58: 2 residues within 4Å:- Chain F: K.279, K.281
Ligand excluded by PLIPACT.59: 4 residues within 4Å:- Chain C: Y.210
- Chain F: F.76, H.173, H.257
Ligand excluded by PLIPACT.60: 1 residues within 4Å:- Chain F: R.148
Ligand excluded by PLIPACT.70: 3 residues within 4Å:- Chain G: N.265, Y.266, K.267
Ligand excluded by PLIPACT.71: 5 residues within 4Å:- Chain G: K.81, R.181, E.248, K.267, D.268
Ligand excluded by PLIPACT.72: 2 residues within 4Å:- Chain G: A.1
- Chain H: Q.140
Ligand excluded by PLIPACT.77: 3 residues within 4Å:- Chain H: T.66, D.67, H.68
Ligand excluded by PLIPACT.78: 2 residues within 4Å:- Chain H: K.279, K.281
Ligand excluded by PLIPACT.79: 4 residues within 4Å:- Chain A: Y.210
- Chain H: F.76, H.173, H.257
Ligand excluded by PLIPACT.80: 1 residues within 4Å:- Chain H: R.148
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, J. et al., Structure-based discovery of a small-molecule inhibitor of methicillin-resistantStaphylococcus aureusvirulence. J.Biol.Chem. (2020)
- Release Date
- 2020-03-25
- Peptides
- Panton-Valentine Leucocidin F: ACEG
Gamma-hemolysin subunit A: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.04 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 12 x PQJ: fos-choline-14(Non-covalent)
- 40 x SO4: SULFATE ION(Non-functional Binders)
- 28 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, J. et al., Structure-based discovery of a small-molecule inhibitor of methicillin-resistantStaphylococcus aureusvirulence. J.Biol.Chem. (2020)
- Release Date
- 2020-03-25
- Peptides
- Panton-Valentine Leucocidin F: ACEG
Gamma-hemolysin subunit A: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B